Serious Infection After Acute Myocardial Infarction
- 1 July 2012
- journal article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 5 (7), 769-776
- https://doi.org/10.1016/j.jcin.2012.03.018
Abstract
No abstract availableFunding Information
- National Institutes of Health (T32 HL079896)
- AstraZeneca
- Bristol-Myers Squibb
- diaDexus
- Eli Lilly & Company
- GlaxoSmithKline
- Merck & Co.
- Murdock Study
- NHLBI
- Regado Biosciences Inc.
- NHLBI
- AHRQ
- Johnson & Johnson
- AstraZeneca
- Bristol-Myers Squibb
This publication has 38 references indexed in Scilit:
- A Model for Predicting Mortality in Acute ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2010
- Cardiac Catheterization Complicated by Iliacus Abscess: A Rare Complication of Transfemoral ApproachAngiology, 2005
- Usual interstitial pneumonia associated with cytomegalovirus infection after percutaneous transluminal coronary angioplastyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Prospective study of bacteremia aftercardiac catheterizationThe American Journal of Cardiology, 2003
- Bacteremia associated with percutaneous transluminal coronary angioplastyCatheterization and Cardiovascular Diagnosis, 1995
- Myocardial abscess due to Fusobacterium following acute myocardial infarctionClinical Cardiology, 1988
- Fever after acute myocardial infarction in patients treated with intravenous timolol or placebo.Heart, 1987
- Duration of Hospital Stay and Post- Myocardial Infarction Morbidity and Mortality: A Kaiser-Permanente ExperienceAngiology, 1981
- The temperature course in acute myocardial infarctionAmerican Heart Journal, 1978
- Suppuration within an acute myocardial infarct with rupture and tamponadeThe American Journal of Cardiology, 1966